Our results indicate that while PRLR expression is down regulated in TNBC in comparison to other breast cancer molecular subtypes, intermediate/high PRLR mRNA levels are still preserved in ~30% of TNBC cases. This evidence concerns the gene PRLR and breast carcinoma.